bms-986446
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 13, 2023 (NCT06084598)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06955741 | Phase 1 | May 5, 2025 | Bristol-Myers Squibb |
| NCT06268886 | Phase 2 | Mar 20, 2024 | Bristol-Myers Squibb |
| NCT06084598 | Phase 1 | Oct 13, 2023 | Bristol-Myers Squibb |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1